Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015
- PMID: 29376465
- DOI: 10.1080/03009742.2017.1405461
Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015
Abstract
Objective: To explore the burden of gout in the Nordic region, with a population around 27 million in 2015 distributed across six countries.
Method: We used the findings of the 2015 Global Burden of Diseases study to report prevalence and disability associated with gout in the Nordic region.
Results: From 1990 to 2015, the number of prevalent gout cases rose by 30% to 252 967 [95% uncertainty interval (UI) 223 478‒287 288] in the Nordic region. In 2015, gout contributed to 7982 (95% UI 5431‒10 800) years lived with disability (YLDs) in the region, an increase of 29% (95% UI 24‒35%) from 1990. While the crude YLD rate of gout increased by 12.9% (95% UI 7.8‒18.1%) between 1990 and 2015, the age-standardized YLD rate remained stable. Gout was ranked as the 63rd leading cause of total YLDs in the region in 2015, with the highest rank in men aged 55-59 years (38th leading cause of YLDs). The corresponding rank at the global level was 94. Of 195 countries studied, four Nordic countries [Greenland (2nd), Iceland (12th), Finland (14th), and Sweden (15th)] were among the top 15 countries with the highest age-standardized YLD rate of gout.
Conclusion: The burden of gout is rising in the Nordic region. Gout's contribution to the total burden of diseases in the region is more significant than the global average. Expected increases in gout burden owing to population growth and ageing call for stronger preventive and therapeutic strategies for gout management in Nordic countries.
Similar articles
-
Burden of rheumatoid arthritis in the Nordic region, 1990-2015: a comparative analysis using the Global Burden of Disease Study 2015.Scand J Rheumatol. 2018 Mar;47(2):1-101. doi: 10.1080/03009742.2017.1314002. Epub 2017 Aug 2. Scand J Rheumatol. 2018. PMID: 28766390
-
Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990-2017: A Systematic Analysis of the Global Burden of Disease Study 2017.Arthritis Rheumatol. 2020 Nov;72(11):1916-1927. doi: 10.1002/art.41404. Epub 2020 Sep 10. Arthritis Rheumatol. 2020. PMID: 32755051
-
High and rising burden of hip and knee osteoarthritis in the Nordic region, 1990-2015.Acta Orthop. 2018 Apr;89(2):177-183. doi: 10.1080/17453674.2017.1404791. Epub 2017 Nov 21. Acta Orthop. 2018. PMID: 29160139 Free PMC article.
-
The global burden of gout: estimates from the Global Burden of Disease 2010 study.Ann Rheum Dis. 2014 Aug;73(8):1470-6. doi: 10.1136/annrheumdis-2013-204647. Epub 2014 Mar 3. Ann Rheum Dis. 2014. PMID: 24590182 Review.
-
Global burden of gout in 1990-2019: A systematic analysis of the Global Burden of Disease study 2019.Eur J Clin Invest. 2023 Apr;53(4):e13937. doi: 10.1111/eci.13937. Epub 2023 Jan 7. Eur J Clin Invest. 2023. PMID: 36511834 Review.
Cited by
-
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target.RMD Open. 2021 Mar;7(1):e001628. doi: 10.1136/rmdopen-2021-001628. RMD Open. 2021. PMID: 33782189 Free PMC article.
-
Gout and Hospital Admission for Ambulatory Care-Sensitive Conditions: Risks and Trajectories.J Rheumatol. 2022 Jul;49(7):731-739. doi: 10.3899/jrheum.220038. Epub 2022 Apr 15. J Rheumatol. 2022. PMID: 35428711 Free PMC article.
-
Educational inequalities in all-cause and cause-specific mortality among people with gout: a register-based matched cohort study in southern Sweden.Int J Equity Health. 2019 Oct 28;18(1):164. doi: 10.1186/s12939-019-1076-1. Int J Equity Health. 2019. PMID: 31660978 Free PMC article.
-
Temporal trends and regional disparity in rheumatoid arthritis and gout hospitalizations in Sweden, 1998-2015.Clin Rheumatol. 2018 Mar;37(3):825-830. doi: 10.1007/s10067-018-3983-8. Epub 2018 Jan 22. Clin Rheumatol. 2018. PMID: 29359231 Free PMC article.
-
Cichorium intybus L. Extract Suppresses Experimental Gout by Inhibiting the NF-κB and NLRP3 Signaling Pathways.Int J Mol Sci. 2019 Oct 4;20(19):4921. doi: 10.3390/ijms20194921. Int J Mol Sci. 2019. PMID: 31590257 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous